Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
This study has been completed.
Study NCT00026286 Information provided by National Cancer Institute (NCI)
First Received: November 9, 2001 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Hot Flashes
Menopausal Symptoms
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma, Intraductal, Noninfiltrating
More general conditions related to this trial
Adenocarcinoma
Breast Diseases
Carcinoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Ductal, Lobular, and Medullary
Neoplasms, Glandular and Epithelial
Signs and Symptoms
Skin Diseases
Interventions listed in this trial
conjugated estrogens
medroxyprogesterone
Additional drug interventions recognized in this trial
Estrogens
Estrogens, Conjugated (USP)
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
